321 related articles for article (PubMed ID: 36085429)
1. Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies.
Kuznetsova A; Popova O; Panchenkov D; Dyuzheva T; Ivanov A
Clin Exp Med; 2023 Jul; 23(3):619-643. PubMed ID: 36085429
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities.
Qin Q; Yu R; Eriksson JE; Tsai HI; Zhu H
Cancer Lett; 2024 Jun; 591():216859. PubMed ID: 38615928
[TBL] [Abstract][Full Text] [Related]
3. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.
Alexander JI; Vendramini-Costa DB; Francescone R; Luong T; Franco-Barraza J; Shah N; Gardiner JC; Nicolas E; Raghavan KS; Cukierman E
Sci Rep; 2021 Feb; 11(1):3802. PubMed ID: 33589694
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma.
Sperb N; Tsesmelis M; Wirth T
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752017
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting.
Vaish U; Jain T; Are AC; Dudeja V
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948209
[TBL] [Abstract][Full Text] [Related]
6. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept.
Luo W; Wen T; Qu X
J Exp Clin Cancer Res; 2024 Jan; 43(1):8. PubMed ID: 38167055
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression.
Liang G; Oh TG; Hah N; Tiriac H; Shi Y; Truitt ML; Antal CE; Atkins AR; Li Y; Fraser C; Ng S; Pinto AFM; Nelson DC; Estepa G; Bashi S; Banayo E; Dai Y; Liddle C; Yu RT; Hunter T; Engle DD; Han H; Von Hoff DD; Downes M; Evans RM
Nat Commun; 2023 Dec; 14(1):7791. PubMed ID: 38057326
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.
Niu N; Shen X; Wang Z; Chen Y; Weng Y; Yu F; Tang Y; Lu P; Liu M; Wang L; Sun Y; Yang M; Shen B; Jin J; Lu Z; Jiang K; Shi Y; Xue J
Cancer Cell; 2024 May; 42(5):869-884.e9. PubMed ID: 38579725
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic Effect of Oncolytic Adenovirus on Pancreatic Cancer Stroma].
Nagai Y; Tazawa H; Kikuchi S; Kuroda S; Noma K; Urata Y; Kagawa S; Fujiwara T
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1102-1103. PubMed ID: 38035844
[TBL] [Abstract][Full Text] [Related]
10. Collagen Lattice Model, Populated with Heterogeneous Cancer-Associated Fibroblasts, Facilitates Advanced Reconstruction of Pancreatic Cancer Microenvironment.
Song X; Nihashi Y; Imai Y; Mori N; Kagaya N; Suenaga H; Shin-Ya K; Yamamoto M; Setoyama D; Kunisaki Y; Kida YS
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612551
[TBL] [Abstract][Full Text] [Related]
11. Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype.
Oh K; Yoo YJ; Torre-Healy LA; Rao M; Fassler D; Wang P; Caponegro M; Gao M; Kim J; Sasson A; Georgakis G; Powers S; Moffitt RA
Nat Commun; 2023 Aug; 14(1):5226. PubMed ID: 37633924
[TBL] [Abstract][Full Text] [Related]
12. Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges.
Srilatha M; Malla R; Adem MP; Foote JB; Nagaraju GP
Semin Cancer Biol; 2023 Dec; 97():12-20. PubMed ID: 37926347
[TBL] [Abstract][Full Text] [Related]
13. Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects.
Polani F; Grierson PM; Lim KH
World J Gastroenterol; 2021 May; 27(18):2105-2121. PubMed ID: 34025067
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies.
Huang H; Lu W; Zhang X; Pan J; Cao F; Wen L
Cell Oncol (Dordr); 2024 Apr; 47(2):383-396. PubMed ID: 37721678
[TBL] [Abstract][Full Text] [Related]
15. Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits.
Maneshi P; Mason J; Dongre M; Öhlund D
Front Cell Dev Biol; 2021; 9():787485. PubMed ID: 34901028
[TBL] [Abstract][Full Text] [Related]
16. Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance.
Sherman MH; Beatty GL
Annu Rev Pathol; 2023 Jan; 18():123-148. PubMed ID: 36130070
[TBL] [Abstract][Full Text] [Related]
17. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer.
Mucciolo G; Araos Henríquez J; Jihad M; Pinto Teles S; Manansala JS; Li W; Ashworth S; Lloyd EG; Cheng PSW; Luo W; Anand A; Sawle A; Piskorz A; Biffi G
Cancer Cell; 2024 Jan; 42(1):101-118.e11. PubMed ID: 38157863
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic landscape of endothelial cells: Key tumor microenvironment components indicating variable clinical outcomes in pancreatic ductal adenocarcinoma.
Xie P; Tan SY; Li HF; Tang HD; Zhou JH
Environ Toxicol; 2024 Feb; 39(2):572-582. PubMed ID: 37449672
[TBL] [Abstract][Full Text] [Related]
19. Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular.
Li O; Li L; Sheng Y; Ke K; Wu J; Mou Y; Liu M; Jin W
Cancer Lett; 2023 Oct; 574():216391. PubMed ID: 37714257
[TBL] [Abstract][Full Text] [Related]
20. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma.
Lee DU; Han BS; Jung KH; Hong SS
Biomol Ther (Seoul); 2024 May; 32(3):281-290. PubMed ID: 38590092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
